| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 435 | 445 | 890 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 435 | 445 | 890 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 1.598 | 1.128 | 452 | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -1.163 | -683 | 438 | -10 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -1.176 | -696 | 422 | -10 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biosallix Prod Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 5.084 | 4.784 | 5.204 | 5.108 | 5.009 | 4.914 | 4.805 | 4.820 | 4.806 | 4.779 |
| Inventories | 3.325 | 3.291 | 3.235 | 3.176 | 3.115 | 3.056 | 2.988 | 2.997 | 2.988 | 2.971 |
| Receivables | 1.597 | 1.498 | 1.690 | 1.659 | 1.627 | 1.596 | 1.560 | 1.565 | 1.561 | 1.552 |
| Cash | 163 | -5 | 278 | 273 | 268 | 263 | 257 | 258 | 257 | 256 |
| Shareholders Funds | -12.883 | -13.448 | -12.988 | -12.759 | -12.512 | -12.275 | -12.003 | -12.040 | -12.003 | -11.936 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.968 | 18.233 | 18.201 | 17.867 | 17.521 | 17.189 | 16.808 | 16.860 | 16.809 | 16.715 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "129 - 129" | |||||||||
| CAEN Financial Year |
129
|
|||||||||
Comments - Biosallix Prod Srl